All Menu Shortcuts Main Contants Shortcuts


Faculty Directory

Eun Sook LEE

Eun Sook LEE, M.D., Ph.D.
Faculty Appointment
(title, department)
Professor, National Cacner Center Graduate School of Cancer Science and Policy
Area of Expertise
Surgical Oncology
Work Experience
7th President, National Cancer Center (2017-2020)
Head, Program for Immunotherapy Research, National Cancer Center (June 2016 – November 2017)
Director, Precision Medicine Branch, National Cancer Center (March 2016 – June 2016)
Director, Research Institute, National Cancer Center (October 2014 - June 2016)
Chief, Center for Breast Cancer, National Cancer Center (September 2012 - September 2014)
Head, Division of Convergence Technology, National Cancer Center (December 2011 - September 2014)
Professor, Department of General Surgery, Korea University Anam Hospital, Seoul, Korea, (September 2008 - November 2011)
Chief & Staff Surgeon, Center for Breast Cancer, National Cancer Center, Goyang city, Korea (December 2000 - August 2008)
Staff Surgeon, Department of General Surgery, Korea University Ansan Hospital, Ansan city, Korea (September 1995 - November 2000)
Visiting Assistant Professo, Robert Lurie Cancer Center, Northwestern University, Chicago, IL
Assistant Professor, Department of Surgery, College of Medicine, Korea University (September 1996 - November 2000)
Instructor, Department of Surgery, College of Medicine, Korea University, Korea (March 1995 - August 1996)
Postdoctoral Fellowship, Department of Surgical Oncology, January 1994 to March 1994, Department of Biochemistry and Molecular Biology, MD Anderson Cancer Center, Houston, TX (April 1994 - January 1995)
Clinical Instructor, Department of General Surgery, Korea University Hospital, Seoul, Korea (1991 to 1994)
Chief Resident, Department of General Surgery, Korea University HyeHwa Hospital, Seoul, Korea (1990 – 1994)
Resident, Department of General Surgery, Korea University HyeHwa Hospital, Seoul, Korea (1987 – 1990)
Intern, Rotating, Korea University HyeHwa Hospital, Seoul, Korea (1986 – 1987)
Educational Background
Ph. D. in Medicine Korea University Graduate School, Seoul, Korea (1993)
M.A. in Medicine Korea University Graduate School, Seoul, Korea (1989)
B.A. in Doctor of Medicine, Korea University College of Medicine, Seoul, Korea (1986)
Research Interests
Target development in triple negative breast cancer, Patient derived animal model. Mechanism of drug resistance in breast cancer treatment
International Collaboration
Member, SWOG, 2011
Secretary, Organizing Committee Asian Breast Cancer Society, 2000
Member, The Asian Breast Cancer Society, 1997
Member, The American Society of Breast Disease, 1996
2022 SCI-E Androgen Receptor as a Predictive Marker for Pathologic Complete Response in Hormone Receptor?Positive and HER-2?Negative Breast Cancer with Neoadjuvant Chemotherapy: CANCER RESEARCH AND TREATMENT. Online:Published (5.036)

2022 SCI-E Differences in Willingness to Undergo BRCA1/2 Testing and Risk Reducing Surgery among the General Public, Cancer Patients, and Healthcare Professionals: A Large Population-Based Survey: JOURNAL OF PERSONALIZED MEDICINE. 12(5):818~ (3.508)

2022 SCI-E Incorporating Polygenic Risk Scores and Nongenetic Risk Factors for Breast Cancer Risk Prediction Among AsianWomen: JAMA NETWORK OPEN. 5(3):e2149030~ (13.353)

2022 SCI-E Long-term trajectory of postoperative health-related quality of life in young breast cancer patients: a 15 year follow-up study: JOURNAL OF CANCER SURVIVORSHIP. Online:Published (4.062)

2022 SCI-E Therapeutic Targeting of DNA Damage Response in Cancer: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 23(3):1701~ (6.208)

2022 SCI-E Targeted next generation sequencing of circulating tumor DNA provides prognostic information for management in breast cancer patients: ANNALS OF TRANSLATIONAL MEDICINE. 10(2):28~ (3.616)

2021 SCI-E Fear of Cancer Recurrence and Its Negative Impact on Health-Related Quality of Life in Long-term Breast Cancer Survivors: CANCER RESEARCH AND TREATMENT. Online:Published (4.679)

2021 SCI-E Sentinel Lymph Node Biopsy in Breast Cancer Patients With Pathological Complete Response in the Axillary Lymph Node After Neoadjuvant Chemotherapy: JOURNAL OF BREAST CANCER. 24(6):531~541 (3.588)

2021 SCI-E 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer: NEW ENGLAND JOURNAL OF MEDICINE. 385(25):2336~2347 (91.253)

2021 SCI-E Clinical Effectiveness of Hypofractionated Proton Beam Therapy for Liver Metastasis from Breast Cancer: FRONTIERS IN ONCOLOGY. 11:783327~ (6.244)

2021 SCI-E Axillary Lymph Node Dissection Rates and Prognosis From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer: FRONTIERS IN ONCOLOGY. 11:741120~ (6.244)

2021 SCI-E Clinical impact of follow-up imaging on mortality in Korean breast cancer patients: A national cohort study: CANCER MEDICINE. 10(18):6480~6491 (4.452)

2021 SCI-E Patient-Reported Outcomes From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer: FRONTIERS IN ONCOLOGY. 11:608207~ (6.244)

2021 SCI-E Effectiveness of the Korean National Cancer Screening Program in reducing breast cancer mortality: NPJ BREAST CANCER. 7(1):83~ (6.923)

2021 SCI-E ELOVL2: a novel tumor suppressor attenuating tamoxifen resistance in breast cancer: AMERICAN JOURNAL OF CANCER RESEARCH. 11(6):2568~2589 (6.166)

2021 SCI-E Five-year changes in ovarian function restoration in premenopausal patients with breast cancer taking tamoxifen after chemotherapy: An ASTRRA study report: EUROPEAN JOURNAL OF CANCER. 151:190~200 (9.162)

2021 SCI-E Nutrient intakes from supplement and factors associated with supplement use among breast cancer survivors: A cross-sectional study: EUROPEAN JOURNAL OF CANCER CARE. :e13447~ (2.52)

2021 SCI-E Guidelines for Cancer Care during the COVID-19 Pandemic in South Korea: CANCER RESEARCH AND TREATMENT. 53(2):323~329 (4.679)

2021 SCI-E Analysis of the tumor characteristics in young age breast cancer patients using collaborative stage data of the Korea Central Cancer Registry: BREAST CANCER RESEARCH AND TREATMENT. 187(3):785~792 (4.872)

2021 SCI-E Systematic evaluation of scoring methods for Ki67 as a surrogate for 21-gene recurrence score: NPJ BREAST CANCER. 7(1):13~ (6.923)

2021 SCI-E Survival in untreated hepatocellular carcinoma: A national cohort study: PLOS ONE. 16(2):e0246143~ (3.24)

2021 SCI-E Survival of Breast-Conserving Surgery Plus Radiotherapy versus Total Mastectomy in Early Breast Cancer.: ANNALS OF SURGICAL ONCOLOGY. Online:Published (5.344)

2021 SCI-E Criteria for identifying residual tumours after neoadjuvant chemotherapy of breast cancers: a magnetic resonance imaging study: SCIENTIFIC REPORTS. 11(1):634~ (4.38)

2020 SCI-E Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer: CANCER SCIENCE. 111(10):3912~3925 (4.966)

2020 기타 Comparison of clinical outcomes between sentinel lymph node biopsy and axillary lymph node dissection in a single-center Z0011-eligible breast cancer cohort: Korean Journal of Clinical Oncology. 16(1):18~24 (0)

2020 SCI-E Efficacy of neoadjuvant endocrine therapy compared with neoadjuvant chemotherapy in pre-menopausal patients with oestrogen receptor-positive and HER2-negative, lymph node-positive breast cancer: BREAST CANCER RESEARCH. 22(1):54~ (4.988)

2020 SCI-E Efficacy of health coaching and a Web-based program on physical activity, weight, and distress management among cancer survivors: a multi-centered randomised controlled trial: PSYCHO-ONCOLOGY. Online:Published (3.006)

2020 SCI-E Role of aldehyde dehydrogenases, alcohol dehydrogenase 1B genotype, alcohol consumption, and their combination in breast cancer in East-Asian women: SCIENTIFIC REPORTS. 10(1):6564~ (3.998)

2020 SCI-E Prediction of Cancer Incidence and Mortality in Korea, 2020: CANCER RESEARCH AND TREATMENT. 52(2):351~358 (3.761)

2020 SCI-E Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017: CANCER RESEARCH AND TREATMENT. 52(2):335~350 (3.761)

2020 SCI-E Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants: NATURE COMMUNICATIONS. 11(1):1217~ (12.121)

2020 SCI-E Comparing the Characteristics and Outcomes of Male and Female Breast Cancer Patients in Korea: Korea Central Cancer Registry: CANCER RESEARCH AND TREATMENT. 52(3):739~746 (3.761)

2020 SCI-E Reliability and Validity of the Korean Language Version of the U.S. National Cancer Institute's Patient-Reported Outcomes Common Terminology Criteria for Adverse Events: JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. 59(5):1082~1088 (3.077)

2020 SCI-E Detection of Germline Mutations in Breast Cancer Patients with Clinical Features of Hereditary Cancer Syndrome Using a Multi-Gene Panel Test: CANCER RESEARCH AND TREATMENT. 52(3):679~713 (3.761)

2020 SCI-E Use of Gadoxetic Acid-enhanced Liver MRI and Mortality in More than 30?000 Patients with Hepatocellular Carcinoma: A Nationwide Analysis: RADIOLOGY. 295(1):114~124 (7.931)

2020 SCI-E Views on Precision Medicine among Health Professionals in Korea: A Mixed Methods Study: YONSEI MEDICAL JOURNAL. 61(2):192~197 (1.914)

2019 Profiles of depressive symptoms and the association with anxiety and quality of life in breast cancer survivors: a latent profile analysis: Quakity of Life Reseach. : (2.39)

2019 SCI-E Adherence to the American Cancer Society Guidelines for Cancer Survivors and Health-Related Quality of Life among Breast Cancer Survivors: NUTRIENTS. 11(12):E2924~E2924 (4.171)

2019 SCI Genomic characteristics of triple-negative breast cancer nominate molecular subtypes that predict chemotherapy response: Molecular Cancer Research. 18(2):253~263 (4.484)

2019 SCI Adding ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Ransdomized Phase 3 Trial: JOURNAL OF CLINICAL ONCOLOGY. Online:Published (28.349)

2019 SCI-E Outcomes of Pregnancy after Breast Cancer in Korean Women: A Large Cohort Study: CANCER RESEARCH AND TREATMENT. 52(2):426~437 (3.363)

2019 SCI-E Night-shift work and risk of breast cancer in Korean women: Clinical Epidemiology. 11:743~751 (3.178)

2019 SCI-E Dietary Inflammatory Index and Risk of Breast Cancer Based on Hormone Receptor Status: A Case-Control Study in Korea: NUTRIENTS. Online:Published (4.171)

2019 SCI The Sentinel Lymph Node Biopsy Using Indocyanine Green Fluorescence Plus Radioisotope Method Compared With the Radioisotope-Only Method for Breast Cancer Patients After Neoadjuvant Chemotherapy: A Prospective, Randomized, Open-Label, Single-Center Phase 2 Trial: ANNALS OF SURGICAL ONCOLOGY. 26(8):2409~2416 (3.681)

2019 SCI Night-shift work, circadian and melatonin pathway related genes and their interaction on breast cancer risk: evidence from a case-control study in Korean women: Scientific Reports. 9(1):10982~10982 (4.011)

2019 SCI Different Patterns of Conditional Survival of Breast Cancer Patients by Age and Histologic types: Evidence from the Korean Nationwide Registry: CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION. 28(7):1169~1176 (5.057)

2019 SCI-E Clinical Significance of Lymph-Node Ratio in Determining Supraclavicular Lymph-Node Radiation Therapy in pN1 Breast Cancer Patients Who Received Breast-Conserving Treatment (KROG 14-18): A Multicenter Study: CANCERS. 11(5):E680~E680 (6.162)

2019 SCI Integrative molecular profiling identifies a novel cluster of estrogen receptor-positive breast cancer in very young women: cancer science. 110(5):1760~1770 (4.751)

2019 SCI Effect of Antihypertensive Medications on Sepsis-Related Outcomes: A Population-Based Cohort Study: Critical Care Medicine. 47(5):e386~e393 (6.971)

2019 SCI-E Integrative In Vivo Drug Testing Using Gene Expression Signature and Patient-Derived Xenografts from Treatment-Refractory HER2 Positive and Triple-Negative Subtypes of Breast Cancer: CANCERS. 11(4):E574~E574 (6.162)

2019 SCI-E Prognostic Value of Post-Diagnosis Health-Related Quality of Life for Overall Survival in Breast Cancer: Findings from a 10-Year Prospective Cohort in Korea: CANCER RESEARCH AND TREATMENT. Online:Published (3.363)

2019 SCI-E Delayed IL-21 treatment preferentially expands peptide-specific CD8+ T cells by reducing bystander activation of T cells: IMMUNOTHERAPY. 11(6):497~513 (3.028)

2019 SCI-E Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016: CANCER RESEARCH AND TREATMENT. 51(2):417~430 (3.363)

2019 SCI-E Prediction of Cancer Incidence and Mortality in Korea, 2019: CANCER RESEARCH AND TREATMENT. 51(2):431~437 (3.363)

2019 SCI-E Interaction Effect Between Breast Density and Reproductive Factors on Breast Cancer Risk in Korean Population: EUROPEAN JOURNAL OF CANCER PREVENTION. 24(1):26~32 (2.33)

2019 SCI Retrospectively validating the results of the ACOSOG Z0011trial in alarge Asian Z0011-eligible cohort: BREAST CANCER RESEARCH AND TREATMENT. Online:Published (3.471)

2019 SCI-E Prediagnosis obesity and secondary primary cancer risk in female cancer survivors: A national cohort study: CANCER MEDICINE. 8(2):824~838 (3.357)

2019 기타 Parity Differently Affects the Breast Cancer Specific Survival from Ductal Carcinoma In Situ to Invasive Cancer: A Registry-Based Retrospective Study from Korea: Breast Cancer : Basic and Clinical Research. 13:1~8 (0)

2019 SCI-E Direct isolation and characterization of circulating exosomes from biological samples using magnetic nanowires: Journal of Nanobiotechnology. 17(1):1~1 (5.345)

2019 SCI-E Clinical Implication of subcategorizing T2 category into T2a and T2b in TNM staging of breast cancer: CANCER MEDICINE. 11:5514~5524 (3.357)

2018 SCI-E Different Patterns of Risk Reducing Decisions in Affected or Unaffected BRCA Pathogenic Variant Carriers: CANCER RESEARCH AND TREATMENT. 51(1):280~288 (3.23)

2018 SCI-E Psychosocial Health of Disease-Free Breast Cancer Survivors Compared with Matched Non-cancer Controls: CANCER RESEARCH AND TREATMENT. 51(1):178~186 (3.23)

2018 SCI-E Predicting Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: combined Statistical Modeling Using Clinicopathological Factors and FDG PET/CT Texture Parameters: clinical nuclear medicine. 44(1):21~29 (6.309)

2018 SCI-E Magnetic Resonance Imaging (MRI) Assessment of Residual Breast Cancer After Neoadjuvant Chemotherapy: Relevance to Tumor Subtypes and MRI Interpretation Threshold.: Clinical breast cancer. 18(6):459~467 (2.703)

2018 SCI-E Doxorubicin-induced heart failure in cancer patients: A cohort study based on the Korean National Health Insurance Database: CANCER MEDICINE. 7(12):6084~6092 (3.202)

2018 SCI Prognostic impact of skeletal muscle volume derived from crosssectional computed tomography images in breast cancer: BREAST CANCER RESEARCH AND TREATMENT. 172(2):425~436 (3.605)

2018 SCI Clinical subtypes and prognosis of pregnancy-associated breast cancer: results from the Korean Breast Cancer Society Registry database: BREAST CANCER RESEARCH AND TREATMENT. 172(1):113~121 (3.605)

2018 SCI Differences in attitudes toward genetic testing among the public,patients, and health-care professionals in Korea: European journal of human genetics. 26(10):1432~1440 (3.636)

2018 SCI-E Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy: Clinical breast cancer. 18(5):e1165~e1172 (2.703)

2018 SCI Factors associated with physical activity of breast cancer patients participating in exercise intervention: SUPPORTIVE CARE IN CANCER. Online:Published (2.676)

2018 SCI-E Incidence of Diabetes After Cancer Development : A Korean National Cohort Study: JAMA oncology. 4(8):1099~1105 (20.871)

2018 SCI-E Comparison of INDEL Calling Tools with Simulation Data and Real Short-Read Data: IEEE/ACM transactions on computational biology and bioinformatics. Online:Published (2.428)

2018 SCI Use of adjuvant chemotherapy in hormone receptor-positive breast cancer patients with or without the 21-gene expression assay: Breast cancer research and treatment. 170(1):69~76 (3.605)

2018 기타 BRACA1/2유전자 검사의 국내 시행현황(2014): Laboratory Medicine Online. 8(3):107~113 (0)

2018 SCI Tamoxifen therapy improves overall survival in luminal A subtype of ductal carcinoma in situ: a study based on nationwide Korean Breast Cancer Registry database: Breast cancer research and treatment. 169(2):311~322 (3.605)

2018 SCI-E Dietary pattern and health-related quality of life among breast cancer survivors: BMC women's health. 18(1):65~65 (1.806)

2018 SCI-E Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015: CANCER RESEARCH AND TREATMENT. 50(2):303~316 (3.23)

2018 SCI-E Prediction of Cancer Incidence and Mortality in Korea, 2018: CANCER RESEARCH AND TREATMENT. 50(2):317~323 (3.23)

2018 SCI-E Increasing Trend in Hospital Deaths Consistent among Older Decedents in Korea: A Population-based Study Using Death Registration Database, 2001?2014: BMC palliative care. 2018(17):16~16 (2.335)

2017 SCI Development and validation of the smart management strategy for health assessment tool-short form (SAT-SF) in cancer survivors: Quality of Life Research. 27(2):347~354 (2.344)

2017 SCI Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy: Breast Cancer Research and Treatment. 166(2):473~480 (3.626)

2017 SCI-E Prognostic Impact of Elective Supraclavicular Nodal Irradiation for Patients with N1 Breast Cancer after Lumpectomy and Anthracycline plus Taxane-based Chemotherapy (KROG 1418): A Multicenter Case-Controlled Study: Cancer Research and Treatment. 49(4):970~980 (3.772)

2017 SCI-E A Novel Germline Mutation in BRCA1 Causes Exon 20 Skipping in a Korean Family with a History of Breast Cancer: Journal of breast cancer. 20(3):310~313 (2.204)

2017 SCI-E Prevalence and survival prognosis of prostate cancer in patients with end-stage renal disease: A retrospective study based on the Korea National Database (2003-2010): Oncotarget. Online:Published (5.168)

2017 SCI-E CKAP2 (cytoskeleton-associated protein2) is a new prognostic marker in HER2-negative luminal type breast cancer: PLOS ONE. 12(8):e0182107~e0182107 (2.806)

2017 SCI The association between physical activity and health-related quality of life among breast cancer survivors: Health Qual Life Outcomes. 15(1):132~132 (2.143)

2017 SCI Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy: The New England journal of medicine. 376(22):2147~2159 (72.406)

2017 SCI-E Tumor-derived IL-18 induces PD-1 expression on immunosuppressive NK cells in triple-negative breast cancer: Oncotarget. 8(20):32722~32730 (5.168)

2017 SCI-E A randomized controlled trial of physical activity, dietary habit, and distress management with the Leadership and Coaching for Health (LEACH) program for disease-free cancer survivors.: BMC Cancer. 17(1):298~298 (3.288)

2017 SCI Characteristics of BRCA1/2 mutations carriers including large genomic rearrangements in high risk breast cancer patients: Breast Cancer Research and Treatment. 163(1):139~150 (3.626)

2017 SCI A Microfluidic Immunostaining System Enables Quality Assured and Standardized Immunohistochemical Biomarker Analysis: Scientific reports. 7:45968~45968 (4.259)

2016 SCI-E Post-mastectomy Radiotherapy in Patients with pT1-2N1 Breast Cancer Treated with Taxane-based Chemotherapy: A Retrospective Multicenter Analysis (KROG 1418).: Cancer Research and Treatment. Online:Published (4.245)

2016 SCI-E Optimal radiation dose for patients with one to three lymph node positive breast cancer following breast-conserving surgery and anthracycline plus taxane-based chemotherapy: A retrospective multicenter analysis (KROG 1418): Oncotarget. 8(1):1796~1804 (5.008)

2016 SCI-E Accelerated whole breast irradiation in early breast cancer patients with adverse prognostic features.: Oncotarget. 7(49):81888~81898 (5.008)

2016 SCI Prediagnosis BodyMass Index and Risk of Secondary Primary Cancer in Male Cancer Survivors: A Large Cohort Study: JOURNAL OF CLINICAL ONCOLOGY. 34(34):4116~4124 (20.982)

2016 SSCI Three-Year Prospective Cohort Study of Factors Associated with Return to Work After Breast Cancer Diagnosis.: Journal of Occup Rehabilitation. Online:Published (1.644)

2016 SCI Multifunctional magnetic nanowires: A novel breakthrough for ultrasensitive detection and isolation of rare cancer cells from non-metastatic early breast cancer patients using small volumes of blood: Biomaterials. 106:78~86 (8.387)

2016 SCI-E The Significance of Serum HER2 Levels at Diagnosis on Intrinsic Subtype-Specific Outcome of Operable Breast Cancer Patients: PLOS ONE. 11(10):e0163370~e0163370 (3.057)

2016 SCI Breast cancer-specific mortality in small-sized tumor with node-positive breast cancer: a nation-wide study in Korean breast cancer society.: Breast Cancer Research and Treatment. 159(3):489~498 (4.085)

2016 SCI-E Identification of Prognostic Risk Factors for Transient and Persistent Lymphedema after Multimodal Treatment for Breast Cancer: Cancer Research and Treatment. 48(4):1330~1337 (4.245)

2016 SCI-E Locoregional Recurrence by Tumor Biology in Breast Cancer Patients after Preoperative Chemotherapy and Breast Conservation Treatment: Cancer research and treatment. 48(4):1363~1372 (4.245)

2016 SCI-E Metabolic syndrome in breast cancer survivors with high carbohydrate consumption: The first report in community setting: Clinical Nutrition. Online:Published (4.487)

2016 SCI-E Clinically Significant Unclassified Variants in BRCA1 and BRCA2 Genes Among Korean Breast Cancer Patients: Cancer Research and Treatment. Online:Published (4.245)

2016 SCI-E Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer: BMC Cancer. 16:430~430 (3.265)

2016 SCI-E The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after: BMC Cancer. 16:319~319 (3.265)

2016 SCI-E The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled trial and progress: BMC CANCER. 16:319~319 (3.265)

2016 SCI An aptamer-antibody complex (oligobody) as a novel delivery platform for targeted cancer therapies: Journal of Controlled Release. 229:1~9 (7.441)

2016 SCI Identifying the potential long-term survivors among breast cancer patients with distant metastasis: Annals of oncology. 27(5):828~833 (9.269)

2016 SCI A Comparative Study of Daily 3-Gy Hypofractionated and 1.8-Gy Conventional Breast Irradiation in Early-Stage Breast Cancer: Medicine. 95(19):e3320~e3320 (2.133)

2016 SCI-E Efficient Capture and Isolation of Tumor-Related Circulating Cell-Free DNA from Cancer Patients Using Electroactive Conducting Polymer Nanowire Platforms: Theranostics. 6:828~836 (8.854)

2016 SCI The Author’s Response: Assessment of Breast Cancer Patients’ Knowledge and Decisional Conflict Regarding Tamoxifen Use: Journal of Korean medical science. 31(4):647~647 (1.256)

2015 SCI-E Second Primary Cancer after Diagnosis and Treatment of Cervical Cancer: Cancer research and treatment. 48(2):641~649 (3.318)

2015 SCI-E Effect of Time Interval between Breast-conserving Surgery and Radiation Therapy on Outcomes of Node-positive Breast Cancer Patients Treated with Adjuvant Doxorubicin/Cyclophosphamide followed by Taxane: Cancer research and treatment. 48(2):483~490 (3.318)

2015 SCI-E Prognostic Implications of Tumor-Infiltrating Lymphocytes in Association With Programmed Death Ligand 1 Expression in Early-Stage Breast Cancer: Clinical Breast Cancer. 16(1):51~58 (2.107)

2015 SCI-E Impact of Molecular Subtype Conversion of Breast Cancers after Neoadjuvant Chemotherapy on Clinical Outcome: Cancer research and treatment. 48(1):133~141 (3.318)

2015 SCI Uptake of risk-reducing salpingo-oophorectomy among female BRCA mutation carriers: experience at the National Cancer Center of Korea.: Journal of Cancer Research and Clinical Oncology. 142(1):333~340 (3.081)

2015 SCI-E Identification of Risk Factors for Locoregional Recurrence in Breast Cancer Patients with Nodal Stage N0 and N1: Who Could Benefit from Post-Mastectomy Radiotherapy?: PLoS ONE. 10(12):e0145463~e0145463 (3.234)

2015 SCI-E Patient-reported assessment of self-management strategies of health in cancer patients: development and validation of the Smart Management Strategy for Health Assessment Tool (SAT): Psycho-Oncology. 24(12):1723~1730 (2.443)

2015 SCI Assessment of Breast Cancer Patients’ Knowledge and Decisional Conflict Regarding Tamoxifen Use: Journal of Korean Medical Science. 30(11):1604~1611 (1.266)

2015 SCI The Value of Ki67 in Very Young Women with Hormone Receptor-Positive Breast Cancer: Retrospective Analysis of 9,321 Korean Women.: Annals of surgical oncology. 22(11):3481~3488 (3.93)

2015 SCI Health Behaviors of Cancer Survivors in Nationwide Cross-Sectional Survey in Korea: Higher Alcohol Drinking, Lower Smoking, and Physical Inactivity Pattern in Survivors with Higher Household Income.: Medicine. 94(31):e1214~e1214 (5.723)

2015 SCI-E Breast Cancer-Related Lymphedema after Neoadjuvant Chemotherapy: Cancer research and treatment. 47(3):416~423 (3.318)

2015 SCI Automated measurement of multiple cancer biomarkesr using quantum-dot-based microfluidic immunohistochemistry: Analytical Chemistry. 87(8):4177~4183 (5.636)

2015 SCI Wnt/β-Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells: Cancer Research. 75(8):1691~1702 (9.329)

2015 SCI-E The Clinical Impact of 21-Gene Recurrence Score on Treatment Decisions for Patients with Hormone Receptor-Positive Early Breast Cancer in Korea: Cancer research and treatment. 47(2):208~214 (3.318)

2015 SCI-E Cross-cultural Validation of Cancer Communication Assessment Tool in Korea: Psycho-oncology. 24(2):197~203 (2.443)

2015 SCI A pathway-based approach for identifying biomarkers of tumor progression to trastuzumab-resistant breast cancer: Cancer letters. 356(2 Pt B):880~890 (5.621)

2014 SCI Vaccination with ErbB-2 Peptides Prevents Cancer Stem Cell Expansion and Suppresses the Development of Spontaneous Tumors in MMTV-PyMT Transgenic Mice: Breast Cancer Research and Treatment. 147(1):69~80 ()

2014 SCI-E Lack of effects of peroxisome proliferator-activated receptor gamma genetic polymorphisms on breast cancer risk: a case-control study and pooled analysis: Asian Pacific journal of cancer prevention. 15(21):9093~9099 (1.5)

2014 SCI-E A Web-based self-management exercise and diet intervention for breast cancer survivors: Pilot randomized controlled trial: International journal of nursing studies. 51(12):1557~1567 (2.248)

2014 SCI High Volumetric Breast Density Predicts Risk for Breast Cancer in Postmenopausal, but not Premenopausal, Korean Women: Annals of surgical oncology. 21(13):4124~4132 (3.943)

2014 SCI An integrated multifunctional platform based on biotin-doped conducting polymer nanowires for cell capture, release, and electrochemical sensing: Biomaterials. 35(36):9573~9580 (8.312)

2014 SCI Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II/III breast cancer patients: Breast cancer research and treatment. 148(1):91~98 (4.198)

2014 SCI-E High-purity isolation and recovery of circulating tumor cells using conducting polymer-deposited microfluidic device: Theranostics. 4(11):1123~1132 (7.827)

2014 SCI-E Trends in the aggressiveness of end-of-life care for Korean pediatric cancer patients who died in 2007-2010: PLOS ONE. 9(6):e99888~e99888 (3.534)

2014 SCI-E The association of self-leadership, health behaviors, and posttraumatic growth with health-related quality of life in patients with cancer: PSYCHO-ONCOLOGY. 3582:3582~3582 (4.044)

2014 SCI Low-mass-ion discriminant equation: A new concept for colorectal cancer screening.: International Journal of Cancer. 134(8):1844~1853 (5.007)

2014 SCI Comparison of Sentinel Lymph Node Biopsy Guided by the Multimodal Method of Indocyanine Green Fluorescence, Radioisotope, and Blue Dye Versus the Radioisotope Method in Breast Cancer: A Randomized Controlled Trial: Annals of Surgical Oncology. 21(4):1254~1259 (3.943)

2014 SCI-E A Quantum Dot-Based Microfluidic Multi-Window Platform for Quantifying the Biomarkers of Breast Cancer Cells: Integr Biol (Camb). 6(4):430~437 (3.996)

2014 SCI An Electroactive Biotin-Doped Polypyrrole Substrate That Immobilizes and Releases EpCAM-Positive Cancer Cells: Angewandte Chemie (International ed. in English). 53(18):4597~4602 (11.336)

2014 SCI-E Association of Polymorphisms and Haplotypes in the Insulin-Like Growth Factor 1 Receptor (IGF1R) Gene with the Risk of Breast Cancer in Korean Women.: PLOS One. 9(1):e84532~e84532 (3.534)

2013 SCI-E Efficacy of a training program for long-term disease- free cancer survivors as health partners: a randomized controlled trial in Korea.: Asian Pacific journal of cancer prevention. 14(12):7229~7235 (1.271)

2013 SCI Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients: Breast Cancer Research and Treatment. 142(3):559~567 (4.469)

2013 SCI Phase 2 trial of accelerated, hypofractionated whole-breast irradiation of 39 Gy in 13 fractions followed by a tumor bed boost sequentially delivering 9 Gy in 3 fractions in early-stage breast cancer: International Journal of Radiation Oncology Biology Physics. 87(5):1037~1042 (4.524)

2013 SCI A Model to Estimate the Risk of Breast Cancer-Related Lymphedema: Combinations of Treatment-Related Factors of the Number of Dissected Axillary Nodes, Adjuvant Chemotherapy, and Radiation Therapy: International Journal of Radiation Oncology, Biology, Physics. 86(3):498~503 (4.524)

2013 SCI The attitudes of Korean cancer patients, family caregivers, oncologists, and members of the general public toward advance directives: Support Care Cancer. 2013(21):1437~1444 (2.649)

2012 SCI-E Prognostic implication of thyroglobulin and quantified whole body scan after initial radioiodine therapy on early prediction of ablation and clinical response for the patients with differentiated thyroid cancer: Annals of Nuclear Medicine. 26(10):777~786 (1.502)

2012 SCI Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference: Breast Cancer Research and Treastment. 136(3):919~926 (4.431)

2012 SCI Predicting Nonsentinel Lymph Node Metastasis Using Lymphoscintigraphy in Patients with Breast Cancer: The Journal of Nuclear Medicine. 53(11):1693~1700 (6.381)

2012 SCI-E High-content quantum dot-based subtype diagnosis and classification of breast cancer patients using hypermulticolor quantitative single cell imaging cytometry: Nano Today. 7(4):231~244 (15.355)

2012 SCI Polymorphisms in adiposity-related genes are associated with age at menarche and menopause in breast cancer patients and healthy women: Human Reproduction. 27(7):2193~2200 (4.475)

2012 SCI-E Progranulin as a Prognostic Biomarker for Breast Cancer Recurrence in Patients Who Had Hormone Receptor-Positive Tumors: A Cohort study: PLOS ONE. 7(6):e39880~e39880 (4.092)

2012 SCI Phase II trial of preoperative paclitaxel, gemcitabine, and trastuzumab combination therapy in HER2 positive stage II/III breast cancer: The Korean Cancer Study Group BR 07-01: Breast Cancer Res Treat. 132(2):589~600 (4.431)

2012 SCI-E Prostate stem cell antigen single nucleotide polymorphisms influence risk of estrogen receptor negative breast cancer in Korean females.: Asian Pacific Journal of Cancer Prevention. 13(1):41~48 (0.659)

2011 SCI-E Locoregional Recurrence of Breast Conserving Surgery after Preoperative Chemotherapy in Korean Women with Locally Advanced Breast Cancer: Journal of Breast Cancer. 14(4):289~295 (0.179)

2011 SCI Social support and depressive mood 1 year after diagnosis of breast cancer compared with the general female population: a prospective cohort study.: Supportive care in cancer. 19(9):1379~1392 (2.058)

2011 SCI Attitudes of cancer patients, family caregivers, oncologists and members of the general public toward critical interventions at the end of life of terminally ill patients.: Canadian Medical Association Journal. 183(10):e673~e679 (9.015)

2011 SCI Quantitative proteomic profiling of breast cancers using a multiplexed microfluidic platform for immunohistochemistry and immunocytochemistry: Biomaterials. 32(5):1396~1403 (7.882)

2011 SCI Health-Related Quality of Life in Survivors With Breast Cancer 1 Year After Diagosis Compared With the General Population A Prospective Cohort Study: Annals of Surgery. 253(1):101~108 (7.474)

2010 SCI-E Oncological Safety and Quality of Life Associated with Mastectomy and Immediate Breast Reconstruction with a Latissimus Dorsi Myocutaneous Flap.: The breast journal. 16(4):356~361 (1.61)

2010 SCI Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival: Breast Cancer Res Treat. 123:177~187 (4.696)

2010 SCI-E Breast Cancer Diagnosis Using a Microfluidic Multiplexed Immunohistochemistry Platform: PLoS One. Online:Published (4.411)

2010 SCI Dietary Mushroom Intake and the Risk of Breast Cancer Based on Hormone Receptor Status: Nutrition and Cancer. 62:476~483 (1.974)

2010 SCI-E Association of shared decision-making with type of breast cancer surgery: a cross-sectional study: BMC Health Services Research. Online:Published (1.66)

2010 SCI Primary systemic therapy with intermittent weekly paclitaxel plus gemcitabine in patients with stage II and III breast cancer: a phase II trial: Investigational New Drugs. 28(1):83~90 (3.072)

2009 SCI-E Primary Primitive NeuroectodermalTumor of the Breast: a Case Report: Korean J. Radiol. :407~410 (1.049)

2009 SCI Correlates of existential well-being and their association with health-related quality of life in breast cancer survivors compared with the general population: BREAST CANCER RESEARCH AND TREATMENT. :139~150 (4.859)

2009 SSCI Big gap between risk perception for breast cancer and risk factors: Nationwide survey in Korea: Patient Education and Counselling. 76(1):113~9 (2.219)

2009 SCI-E Fatty fish and fish omega-3 fatty acid intakes decrease the breast cancer risk: a case-control study: BMC Cancer. 9(1):216~216 (3.087)

2008 SCI Impact of breast cancer diagnosis and treatment on work-related life and factors affecting them: Breast Cancer Research and Treatment. 116:609~616 (4.453)

2008 SCI Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer: Breast Cancer Res Treat. :335~342 (5.684)

2008 SCI-E Genetic Counseling Can Influence the Course of a Suspected Familial Cancer Syndrome Patient: From a Case of Li-Fraumeni Like Syndrome with a Germline Mutation in the TP53 Gene.: The Korean Journal of Laboratory Medicine. 28:493~497 (0.66)

2008 SCI Scoring system for predicting malignancy in patients diagnosed with atypical ductal hyperplasia at ultrasound-guided core needle biopsy: Breast Cancer Research and Treatment. 112(1):189~195 (4.453)

2008 SCI-E Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability: BMC Cancer. 8:286~295 (2.709)

2008 SCI Increased cytoplasmic levels of CIS, SOCS1, SOCS2, or SOCS3 are required for nuclear translocation: FEBS Letters. 582:2319~2324 (3.263)

2008 SCI Promoter hypomethylation of the N-acetyltransferase 1 gene in breast cancer: Oncology Reports. 19:663~8 (1.597)

2008 SCI Association of clinical experiences with patient-reported outcomes among breast cancer surgery patients: breast cancer quality care study: Quality of Life Research. 17:215~225 (2.466)

2007 SCI A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer.: Breast Cancer Research and Treatment. 109:481~489 (4.671)

2007 SCI Trends in breast cancer treatment in Korea and impact of compliance with consensus recommendations on survival: Breast Cancer Research and Treatment. 106:245~253 (4.453)

2007 SCI Extent of routine central lymph node dissection with small papillary thyroid carcinoma: World Journal of Surgery. 10:1954~1959 (1.765)

2007 SCI Extent of rountine central lymphnode dissection with small palilloary thyroid carcinoma: World Journal Sug. 31:1954~1959 (1.765)

2007 SCI Clinical implications of CYP2D6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancer: Journal of Clinical Oncology. 25:3837~3845 (15.484)

2007 SCI Population-based breast cancer statistics in Korea during 1993-2002: incidence, mortality, and survival: Journal of Korean Medical Science. 22:s11~s16 (0.725)

2007 SCI The nuclear localization of SOCS6 requires the N-terminal region and negatively regulates Stat3 protein levels: Biochemical and Biophysical Research Communications. 360:333~338 (2.855)

2007 SCI Epidermal growth factor receptor status in anaplastic thyroid carcinoma: Journal of Clinical Pathology. 60:881~884 (2.245)

2007 SCI Primary Malignant Teratoma with a Primitive Neuroectodermal Tumor Component in Thyroid Gland: A Case Report: Journal of Korean Medical Science. 22:568~571 (0.725)

2007 기타 The Clinical Characteristics and Predictive Factors of Stage IV Breast Cancer at the Initial Presentation: A Review of a Single Institute’s Data: 한국유방암학회지. 10(2):101~106 ()

2007 기타 The Clinical Characteristics and Predictive Factors of Stage IV Breast Cancer at the Initial Presentation: A Review of a Single Institute’s Data: 한국유방암학회지. 10(2):101~106 ()

2007 SCI Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients: Breast Cancer Research and Treatment. 102:283~288 (4.671)

2007 SCI Increased SOCS6 stability with PMA requires its N-terminal region and the Erk pathway via Pkc activation: Biochemical and Biophysical Research Communications. 354:184~189 (2.855)

2007 SCI Health-related quality of life in disease-free survivors of breast cancer with the general population: Annals of Oncology. 18:173~182 (4.875)

2006 SCI Detection of BRAFV600E mutation on fine-needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAFV600E mutation-prevalent area: CLINICAL ENDOCRINOLOGY. 65:660~666 (3.412)

2006 SCI Predicting tissue HER2 status using serum HER2 levels in patients with metastatic breast cancer: Clinical Chemistry. 52:1510~1515 (7.717)

2006 SCI Serum HER-2 concentration in patients with primary breast cancer: Journal of Clinical Pathology. 59:601~605 (2.17)

2006 SCI Epigenetic silencing of the sulftransferase1A1 gene by hypermethylation in breast tissue: Oncology Reports. 15:27~32 (1.572)

2005 SCI The melanoma antigen gene as a surveillance marker for the detection of circulating tumor cells in patients with breast carcinoma: CANCER. 104:251~256 (4.434)

2005 SCI Incidental ovarian(18)F-FDG accumulation on PET : correlation with the menstrual cycle: European Journal of Nuclear Medicine and Molecular Imaging. 32:757~763 (3.94)

2005 SCI Tamoxifen-resistant breast cancers show less frequent methylation of the estrogen receptor beta but not the estrogen receptor alpha gene: JOURNAL OF MOLECULAR MEDICINE-JMM. 83:132~139 (4.82)

2004 SCI Decreased identification rate of sentinel lymph node after neoadjuvant chemotherapy: World Journal of Surgery. 28:1019~1024 (1.952)

2004 SCI Predictive value of [18F]FDG PET for pathological response of breast cancer to neo-adjuvant chemotherapy: ANNALS OF ONCOLOGY. 15(9):1352~1357 (4.319)

2004 SCI-E CpG methylation of the Erα and Erβ genes in breast cancer: INT J Mol MED. 14:289~293 (1.94)

2004 SCI Validation of the Korean version of the EORTC QLQ-C30: Qual Life Res. 13:863~868 (1.5)

2004 SCI The histone deacetylase inhibitor trichostatin A sensitize estrogen receptor alpha-negative breast cancer cells to tamoxifen: Oncogene. 23:1724~1736 (5.979)

2004 SCI Comparison of plasma D-dimer and thrombus precursor protein in patients with operable breast cancer as a potential predictor of lymph node metastasis: BLOOD COAGUL FIBRIN. 15:9~13 (1.588)

2004 기타 Sentinel lymph node biopsy after neoadjuvant chemotherapy: Breast Cancer. 11:233~241 (0)

2003 SCI Apoptotic Action of 17β-Estradiol in Raloxifene-Resistant MCF-7 Cells In Vitro and In Vivo: J Natl Cancer Inst. 95:1586~1597 (14.5)

2003 SCI Prevalence and Risk of Cancer of Focal Thyroid Incidentaloma Identified by F-18 Fluorodeoxyglucose-Position Emission Tomography for Metastasis Evaluation and Cancer-screening in Healthy Subjects: J Clin Endocrinol Metab. 88:4100~4104 (5.16)

2003 SCI Circulating numbers of endothelial progenitor cells in patients with gastric and breast cancer: Cancer Lett. 198:83~88 (1.741)

2002 SCI Optimized flow cytometric assay for the measurement of platelet microparticles in plasma : preanalytic and analytic considerations: BLOOD COAGUL FIBRIN. 13(5):393~397 (0.581)

2001 SCI The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer: J Mol Med. 79:648~655 (3.445)

2001 SCI Silencing and Reactivation of the Selective Estrogen Receptor Modulator-Estrogen Receptor α Complex: Cancer lett. 61:3632~3639 (8.649)